Logic of Selecting Suitable Dissolution Parameters in New Drug Formulations Based on A BCS Approach
| Author | Raúl Medina-López | en |
| Author | Edgar E. Arregui | en |
| Author | Edson J. Aranda | en |
| Author | Luis A. Moreno-Rocha | en |
| Author | Marcela Hurtado | en |
| Author | Helgi Jung-Cook | en |
| Author | Sally A. Helmy | en |
| Issued Date | 2020-01-31 | en |
| Abstract | Since the biopharmaceutical quality of generic drug formulations depends on the quality of the reference products and also information about the in-vitro release performance of drugs under different conditions is scarce in the literature, a dissolution study of four reference tablets was performed. Each drug was representative of one Class of the Biopharmaceutical Classification System. The in-vitro release performance of propranolol-HCl, carbamazepine, ranitidine-HCl, and metronidazole was evaluated using a USP basket and paddle apparatus at different agitation rates (50, 75, and 100 rpm) with two doses of each drug. In all experiments, pharmacopeial dissolution media was used and the samples were taken with automatic equipment at specific times up to 60 min, except for propranolol-HCl, for which the samples were taken up to 30 min. The dissolution profiles were compared by model-independent, model-dependent, and ANOVA-based comparisons. The three methods of data comparison showed that low vs. high doses were significantly different (P | en |
| DOI | https://doi.org/10.22037/ijpr.2020.1100993 | en |
| Keyword | Carbamazepine | en |
| Keyword | Dose | en |
| Keyword | Metronidazole | en |
| Keyword | Propranolol-HCl | en |
| Keyword | Ranitidine-HCl | en |
| Keyword | Reference products | en |
| Publisher | Brieflands | en |
| Title | Logic of Selecting Suitable Dissolution Parameters in New Drug Formulations Based on A BCS Approach | en |
| Type | Original Article | en |